amlodipine has been researched along with bisoprolol in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (9.86) | 18.2507 |
2000's | 16 (22.54) | 29.6817 |
2010's | 33 (46.48) | 24.3611 |
2020's | 15 (21.13) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adegbile, IA; Alemayehu, D; Carr, AA; Lefkowitz, MP; Papademetriou, V; Prisant, LM; Weber, MA; Weir, MR | 1 |
Meyer, C | 1 |
Adegbile, IA; Alemayehu, D; Lefkowitz, MP; Papademetriou, V; Prisant, LM; Weber, MA; Weir, MR | 1 |
Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
Imai, Y; Ohkubo, T; Omae, T; Sekino, M | 1 |
DeQuattro, V; Ferdinand, K; Hall, WD; Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
DeQuattro, V; Hall, WD; Neutel, JM; Papademetriou, V; Prisant, LM; Weir, MR | 1 |
Benetos, A; Consoli, S; Dubanchet, A; Safar, M; Safavian, A | 1 |
Brown, MJ; Deary, AJ; Foo, RS; Haydock, SF; Murfet, H; Schumann, AL | 1 |
Alexander, GJ; Brown, MJ; Byrne, CD; Neal, DA; Wilkinson, IB | 1 |
Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Miettinen, HE; Paavonen, KJ; Pentikäinen, PJ; Strandberg, T; Suonsyrjä, T; Tikkanen, I; Tilvis, R; Virolainen, J | 1 |
Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
Burckhardt, D; Dubach, P; Erne, P; Kiowski, W; Pfisterer, M; Resink, T; Schoenenberger, AW; Zuber, M | 1 |
Donner, K; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Miettinen, HE; Paavonen, KJ; Pentikäinen, PJ; Strandberg, T; Suonsyrjä, T; Tikkanen, I; Tilvis, R | 1 |
Dabek, J; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Nieminen, MS; Oikarinen, L; Porthan, K; Suonsyrja, T; Toivonen, L; Vaananen, H; Viitasalo, M; Virolainen, J | 1 |
Donner, K; Fodstad, H; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Suonsyrjä, T | 1 |
Abbate, A; Erne, P; Jamshidi, P; Kobza, R; Pfisterer, M; Schoenenberger, AW; Stuck, AE; Zuber, M | 1 |
Antikainen, M; Donner, KM; Hannila-Handelberg, T; Hiltunen, TP; Hirvonen, A; Kontula, K; Suonsyrjä, T; Tikkanen, I | 1 |
Aderibigbe, A; Anisiuba, BC; Ba, SA; Boombhi, HJ; Ijoma, CK; Kamdem, MK; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'buyamba-Kabangu, JR; Mipinda, JB; Ndiaye, MB; Odili, AN; Omotoso, BA; Richart, T; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Kawecka-Jaszcz, K; Rajzer, M; Undas, A; Wojciechowska, W | 1 |
Donner, KM; Hannila-Handelberg, T; Hiltunen, TP; Kontula, K; Suonsyrjä, T | 1 |
Anisiuba, BC; Ba, SA; Boombhi, HJ; Ezeala-Adikaibe, B; Ijoma, CK; Kamdem, MM; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'Buyamba-Kabangu, JR; Ndiaye, MB; Odili, AN; Omotoso, BA; Shu, EN; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Bi, K; Chang, H; Fan, G; Guan, X; Li, J; Qian, Z; Sun, F | 1 |
Afanas'ev, IuI; Grigorova, SIu; Storozhenko, SIu | 1 |
Dussouil, AS; Gaudy-Marqueste, C; Grob, JJ; Mallet, S; Monestier, S; Richard, MA; Tasei, AM | 1 |
Anisiuba, BC; Ba, SA; Boombhi, HJ; Ezeala-Adikaibe, B; Ijoma, CK; Jacobs, L; Kaptue, J; Kingue, S; Kolo, PM; Lemogoum, D; M'Buyamba-Kabangu, JR; Mipinda, JB; Ndiaye, MB; Odili, A; Omotoso, BA; Osakwe, CE; Staessen, JA; Thijs, L; Ulasi, II | 1 |
Chekman, IS; Horchakova, NO; Kuftyreva, TP; Puzyrenko, AM | 1 |
Juszkat, R; Niklas, A; Piekarska, A; Stryczyński, L; Tykarski, A | 1 |
Dobrokhod, AS; Kushnir, SM; Radchenko, GD; Sirenko, YM; Torbas, OO | 1 |
Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Donner, KM; Frau, F; Glorioso, N; Glorioso, V; Gong, Y; Gums, JG; Hiltunen, TP; Johnson, JA; Kontula, KK; Ripatti, S; Saarela, J; Salvi, E; Sarin, AP; Turner, ST; Zaninello, R | 1 |
Chesnikova, AI; Kolomatskaia, OE; Safronenko, VA | 1 |
Czarnecka, D; Gottwald-Hostalek, U; Koch, EM | 1 |
Bula, MS; Virna, MM; Zaremba, IeKh; Zaremba, OV; Zaremba-Fedchyshyn, OV | 1 |
El-Zeany, BA; Elzanfaly, ES; Hassan, SA; Salem, MY | 1 |
Fendrikova, AV; Malchikova, SV; Sirotenko, DV; Skibitskiy, AV; Skibitskiy, VV; Tariovskaya, EI | 1 |
Piecha, G; Skoczylas, A; Więcek, A | 1 |
Barho, C; Gottwald-Hostalek, U; Hildemann, S; Sun, N | 1 |
Cohen, BJ | 1 |
Bogomaz, AV; Kobalava, ZD; Kotovskaya, YV | 1 |
Gridina, SA; Povetkin, SV | 1 |
Higa, A; Hoshi, H; Imai, JI; Ito, E; Morisawa, G; Takagi, M; Watanabe, S; Yanagisawa, Y | 1 |
Armario, P; Banegas, JR; de la Cruz, JJ; de la Sierra, A; Gorostidi, M; Oliveras, A; Ruilope, LM; Segura, J; Vinyoles, E | 1 |
Chen, X; Gao, D; Hu, C; Hu, X; Huang, Y; Li, L; Wang, C; Zhang, L; Zhao, Z; Zhou, D | 1 |
Ding, Y; Li, X; Liu, J; Liu, Y; Niu, J; Wu, M; Zhang, H | 1 |
Grigorieva, NY; Ilyushina, TP; Yashina, EM | 1 |
Atkins, ER; Billot, L; Chalmers, J; Chow, CK; Hay, P; Hillis, GS; Neal, B; Nelson, M; Patel, A; Reid, CM; Rodgers, A; Schlaich, M; Usherwood, T; Webster, R | 1 |
Ahmed, HM; Belal, TS; El Yazbi, FA; Elonsy, SM; Shaalan, RA | 1 |
Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E | 1 |
Atkins, ER; Billot, L; Burke, M; Chalmers, J; Chow, CK; Hay, P; Hillis, GS; Neal, B; Nelson, MR; Patel, A; Reid, CM; Rodgers, A; Rogers, K; Schlaich, MP; Usherwood, T; Webster, R | 1 |
Abdelazeem, AM; El-Khodary, NM; Elghoneimy, HA; Helmy, MW; Youssef, AM | 1 |
Feifel, J; Foch, C; Gottwald-Hostalek, U | 1 |
Abdelazim, AH; Ramzy, S; Shahin, M | 1 |
Gaciong, Z; Hostalek-Gottwald, U | 1 |
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
Böhm, M; Götzinger, F; Hohl, M; Hübner, U; Lauder, L; Lehnert, U; Mahfoud, F; Meyer, MR; Schneider, C; Sevimli, Ö; Tokcan, M; Wagmann, L | 1 |
Hsieh, PC; Lan, CC; Su, WL; Tzeng, IS; Wu, CW; Wu, YK; Yang, MC | 1 |
Tchernev, G | 3 |
2 review(s) available for amlodipine and bisoprolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension.
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Humans; Hypertension; Observational Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
32 trial(s) available for amlodipine and bisoprolol
Article | Year |
---|---|
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Bisoprolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life; United States | 1995 |
Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Enalapril; Female; Humans; Male; Middle Aged; Quality of Life | 1996 |
Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1998 |
Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Bisoprolol; Black People; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1999 |
Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies.
Topics: Amlodipine; Bisoprolol; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1998 |
Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life; Safety; Sodium Chloride Symporter Inhibitors; Systole; Treatment Outcome | 2000 |
Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors | 2002 |
Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation.
Topics: Adult; Aged; Aldosterone; Amlodipine; Antihypertensive Agents; Bisoprolol; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Renin; Treatment Outcome | 2004 |
Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Finland; Genetic Variation; Genotype; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Phenotype; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Time Factors; Treatment Outcome | 2007 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Bisoprolol; Death, Sudden, Cardiac; Humans; Middle Aged; Molsidomine; Myocardial Infarction; Myocardial Ischemia; Patient Compliance; Pilot Projects; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium; Cross-Over Studies; Double-Blind Method; Forecasting; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Renin; Sodium; Treatment Outcome | 2008 |
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.
Topics: Action Potentials; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrophysiology; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Ventricular Function | 2009 |
Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
Topics: Adult; Amlodipine; Angiotensinogen; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calmodulin-Binding Proteins; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2009 |
Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Bisoprolol; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Molsidomine; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Regression Analysis; Risk Factors; Switzerland; Vasodilator Agents | 2009 |
CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Bisoprolol; Cross-Over Studies; Cytochrome P-450 CYP2C9; Double-Blind Method; Drug Resistance; Electrolytes; Gene Frequency; Genotype; Humans; Hypertension, Renal; Losartan; Male; Middle Aged; Placebos; Renin; Renin-Angiotensin System | 2009 |
Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Combinations; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Research Design; Risk Factors; Tetrazoles; Valine; Valsartan | 2011 |
Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication.
Topics: Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Coagulation; Female; Fibrin; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2012 |
Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.
Topics: Administration, Oral; Adult; Africa South of the Sahara; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Bisoprolol; Black People; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Dropouts; Patient Selection; Risk Factors; Tablets; Tetrazoles; Time Factors; Treatment Outcome | 2012 |
Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Bisoprolol; Black People; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Diuretics; Doxazosin; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Time Factors; Treatment Outcome; Ukraine; Vascular Stiffness | 2013 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
Topics: Adult; Aldehyde Oxidoreductases; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Blood Pressure Monitoring, Ambulatory; Chloride Channels; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Essential Hypertension; Finland; Genome-Wide Association Study; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Membrane Proteins; Meta-Analysis as Topic; Microfilament Proteins; Middle Aged; Mutation, Missense; Pharmacogenetics; Polymorphism, Single Nucleotide; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2015 |
[Amlodipine and bisoprolol application in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Drug Combinations; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged | 2014 |
[Pharmacoeconomic Efficacy of a Fixed Combination of Bisoprolol and Amlodipine].
Topics: Aged; Amlodipine; Antihypertensive Agents; Aorta; Bisoprolol; Blood Pressure; Costs and Cost Analysis; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Vascular Stiffness | 2015 |
Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
Topics: Adolescent; Adult; Amlodipine; Antihypertensive Agents; Bisoprolol; China; Cross-Over Studies; Drug Combinations; Fasting; Female; Healthy Volunteers; Humans; Male; Middle Aged; Tablets; Therapeutic Equivalency; Young Adult | 2018 |
S-amlodipine-bisoprolol combination therapy caused elevated transaminases and triglyceride levels in healthy Chinese subjects: a randomized controlled, open-label, multiple-dose pharmacokinetic interaction study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Antihypertensive Agents; Area Under Curve; Asian People; Bisoprolol; Drug Interactions; Drug Therapy, Combination; Humans; Middle Aged; Stereoisomerism; Transaminases; Triglycerides; Young Adult | 2019 |
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Humans; Hypertension; Indapamide; Irbesartan; Outcome Assessment, Health Care; Sample Size | 2021 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Topics: Amlodipine; Antihypertensive Agents; Australia; Bisoprolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Irbesartan; Male; Middle Aged; Treatment Outcome | 2021 |
Effect of amlodipine versus bisoprolol in hypertensive patients on maintenance hemodialysis: A randomized controlled trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome | 2021 |
An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy.
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Humans; Hypertension; Middle Aged; Treatment Outcome | 2022 |
37 other study(ies) available for amlodipine and bisoprolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
New drugs in the cardiovascular arena.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Cardiovascular Diseases; Humans; Quinolines; Sotalol; Vasodilator Agents | 1993 |
Differential effects of antihypertensive drugs with differing pharmacological properties on the basal ambulatory blood pressure. Japanese Ambulatory Pressure-ANtihypertensive Effects SEarching study group.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Lisinopril; Male; Middle Aged; Nifedipine; Office Visits; Systole | 1998 |
STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
Topics: Adult; Alleles; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Genotype; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases | 2012 |
Simultaneous determination of amlodipine and bisoprolol in rat plasma by a liquid chromatography/tandem mass spectrometry method and its application in pharmacokinetic study.
Topics: Amlodipine; Animals; Bisoprolol; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Reverse-Phase; Female; Liquid-Liquid Extraction; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Lisinopril; Middle Aged; Random Allocation; Severity of Illness Index; Treatment Outcome | 2012 |
[Telangiectasia during amlodipine therapy].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Calcium Channel Blockers; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Ramipril; Telangiectasis | 2013 |
[The effect of amlodipine, bisoprolol on the myocardial ultrastructure of the hypertensive rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Capillaries; Drug Combinations; Hypertension; Male; Microscopy, Electron, Scanning; Mitochondria; Myocardium; Myofibrils; Rats; Rats, Inbred SHR | 2013 |
Young woman with idiopathic supradiaphragmatic mid-aortic syndrome and hypertension successfully controlled with a beta-blocker-calcium antagonist fixed-dose combination.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Aorta, Abdominal; Aortic Arch Syndromes; Bisoprolol; Calcium Channel Blockers; Constriction, Pathologic; Drug Combinations; Female; Humans; Hypertension; Young Adult | 2013 |
[Evaluating the effectiveness of a fixed combination of amlodipine and bisoprolol in ambulatory patients with arterial hypertension and ischemic heart disease].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Amlodipine; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Drug Monitoring; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Outpatients; Severity of Illness Index; Treatment Outcome | 2014 |
Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Essential Hypertension; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Poland; Young Adult | 2015 |
Continuous Wavelet Transform, a powerful alternative to Derivative Spectrophotometry in analysis of binary and ternary mixtures: A comparative study.
Topics: Algorithms; Amides; Amlodipine; Bisoprolol; Complex Mixtures; Fumarates; Hydrochlorothiazide; Reproducibility of Results; Signal Processing, Computer-Assisted; Signal-To-Noise Ratio; Spectrophotometry; Wavelet Analysis | 2015 |
Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apelin; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Calcium Channel Blockers; Cytokines; Diuretics; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Obesity; Random Allocation; Resistin; Tetrazoles; Treatment Outcome | 2016 |
Management of Hypertension With a Fixed-Dose (Single-Pill) Combination of Bisoprolol and Amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Patient Compliance; Treatment Outcome | 2017 |
A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients.
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Humans; Hypertension | 2017 |
[The Fixed Combination of Amlodipine and Bisoprolol Eliminates the Effect of -Blockers on Central Pulse Wave in Patients With Arterial Hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Determination; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pulse Wave Analysis | 2015 |
[Comparative Assessment of Effects of Free and Fixed Combinations of Hypotensive Drugs on Quality of Life of Patients With Arterial Hypertension of High and Very High Risk].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Female; Humans; Hypertension; Indapamide; Lisinopril; Male; Middle Aged; Quality of Life; Ramipril; Random Allocation; Surveys and Questionnaires | 2016 |
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression Profiling; Gene Expression Regulation; Humans; Induced Pluripotent Stem Cells; Linagliptin; Long QT Syndrome; Myocytes, Cardiac; Naphthalenes; Phenylpropionates; Piperazines; Prasugrel Hydrochloride; Pyridazines; Sumatriptan; Tetrazoles; Transcriptome; Up-Regulation | 2017 |
Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Mineralocorticoid Receptor Antagonists; Ramipril; Tetrazoles | 2018 |
[Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma].
Topics: Adrenergic beta-Antagonists; Amlodipine; Asthma; Bisoprolol; Coronary Artery Disease; Humans | 2019 |
Application of MEKC and UPLC with Fluorescence Detection for Simultaneous Determination of Amlodipine Besylate and Bisoprolol Fumarate.
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Valsartan | 2021 |
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Bisoprolol; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Telmisartan; Warfarin | 2021 |
Quantitative Analysis of Two Pharmaceutical Combinations Containing Amlodipine with Either Bisoprolol or Candesartan Using Different UV Spectrophotometric Methods.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Humans; Leukemia, Myeloid, Acute; Spectrophotometry; Tablets; Tetrazoles | 2022 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopathies; Denervation; Doxazosin; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Renin; Sympathectomy | 2023 |
Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Bisoprolol; Exercise Test; Humans; Hypertension; Pulmonary Disease, Chronic Obstructive | 2023 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride | 2023 |
NITROSOGENESIS OF CUTANEOUS MELANOMA: SIMULTANEOUSLY DEVELOPMENT OF PRIMARY CUTANEOUS THICK MELANOMA OF THE BREAST, THIN MELANOMA/DYSPLASTIC MOLE OF THE BACK DURING PARALLEL INTAKE OF BISOPROLOL, AMLODIPINE AND VALSARTAN/ HCT: NITROSAMINE POLYCONTAMINATIO
Topics: Amlodipine; Bisoprolol; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mutagens; Skin Neoplasms; Valsartan | 2023 |